OmicScouts is a chemical proteomics company focused on supporting drug and biomarker discovery with its unique expertise and innovative technologies.
Founded by leading proteomics researchers, the company has a track record in delivering significant collaborations with top pharmaceutical and biotechnology companies.
We provide and develop proteome-wide assays that work with native proteins in a physiological setting and enable the identification of small molecule, nucleic acid, or protein drug targets; target engagement markers; molecular mechanisms of action and drug response biomarkers.
OmicScouts supports your drug and biomarker discovery projects with end-to-end solutions tailored to project specific needs.
OmicScouts' technologies enable informed decisions at different stages of the drug discovery process. Generally, our technologies support both traditional, target-based drug discovery and phenotypic, chemical genetics-based drug discovery.
OmicScouts' technologies enable both unbiased biomarker discovery approaches and targeted biomarker discovery/development applications, thereby supporting the translation of basic science into applied clinical research.
OmicScouts' technologies provide access to various kinds of system level information in 100s of samples from different conditions, tissues and/or organisms.
Precision proteomics at the interface of immunology and oncology
Lead Identification and Validation Services
Biochemistry & Molecular Biology Services
OmicScouts GmbH has not received any reviews.
OmicScouts GmbH has not received any endorsements.